Short answer
Trypanosoma brucei testing is used when human African trypanosomiasis, also called sleeping sickness, is suspected after travel or residence in parts of sub-Saharan Africa where tsetse fly transmission occurs. Diagnosis depends on finding the parasite or staging the illness in the right specimen, not on a broad consumer parasite panel.
Who should be tested
Testing belongs in a travel-medicine or infectious-disease workup when fever, chancre, swollen lymph nodes, neurologic changes, or sleep disturbance follow a compatible exposure history. The subspecies matters because geography, symptom tempo, and specimen choice can differ.
How testing differs by stage
| Clinical context | Common diagnostic approach | Important limit |
|---|---|---|
| Early blood or lymph involvement | Microscopy of blood, chancre fluid, or lymph node aspirate may identify parasites. | Routine blood testing can miss the diagnosis. |
| Possible West African disease | Repeated sampling and specialist review may be needed. | Parasitemia can be intermittent or low. |
| Possible nervous-system involvement | Cerebrospinal fluid evaluation may be needed for staging. | Staging affects treatment and urgency. |
What specimens may be used
- Blood smear or concentration methods.
- Lymph node aspirate.
- Chancre fluid when a skin lesion is present.
- Cerebrospinal fluid if second-stage disease is suspected.
Why travel history drives the workup
Exposure history tells the clinician whether the parasite is even plausible. CDC and WHO both frame human African trypanosomiasis as a travel and geography-linked diagnosis, so the first step is usually to match symptoms with a specific exposure window and region before choosing the specimen.
Questions to ask
- Which countries, parks, rivers, or rural areas were involved?
- Do the symptoms suggest early blood/lymph disease or possible nervous-system involvement?
- Which specimen was examined or should be examined next?
- Has infectious disease or CDC consultation been arranged?
FAQ
Who should think about Trypanosoma brucei testing?
People with fever, swollen lymph nodes, neurologic changes, or sleep disturbance after travel to parts of sub-Saharan Africa where tsetse fly exposure is possible should be evaluated urgently.
Does a routine blood test rule it out?
No. CDC notes that diagnosis can require blood, lymph node, chancre, or cerebrospinal fluid testing depending on the stage and subspecies.
Why does the subspecies matter?
T. b. gambiense and T. b. rhodesiense can differ in geography, symptom tempo, and the specimens most likely to help confirm the diagnosis.
Why is cerebrospinal fluid testing sometimes needed?
If nervous-system involvement is suspected, CSF helps determine staging, which guides treatment choice.
Should I wait if symptoms are getting worse?
No. This is a time-sensitive infectious disease workup and should be discussed promptly with a clinician or travel-medicine specialist.
What should I bring to the visit?
Bring your travel dates, countries visited, rural or river exposure, tsetse fly exposure if known, symptom timing, and any prior test results.